health
CRISPR Base Editing of ANGPTL3 Lowered Lipids in Animal Models
A CRISPR base-editing approach targeting ANGPTL3 reduced LDL cholesterol and triglycerides in mouse and nonhuman-primate models. In primates, ANGPTL3 protein reductions lasted up to three years after one dose.